DDX5 and liver cancer: Importantly, DDX5 downregulation, irrespective of HBV replication, increased EpCAM expression (Figure 6C) among other genes, which is a known hepatic cancer stem cell marker 18 and a Wnt/β-catenin signaling target gene 44.